Atorvastatin Calcium Tablet
Product Images NDC 68071-2967

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2967 9)

Atorvastatin Calcium 20mg tablets label from NuCare Pharmaceuticals, Inc., NDC 68071-2967. The label states a package size of 90 tablets and describes the tablets as oval shaped, white to off-white, with 'ATO' debossed on one side and '20' on the other. Includes manufacturer and lot information placeholders and warnings to keep out of reach of children.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 1)

A line graph depicting cumulative incidence (%) over time in years for Atorvastatin compared to placebo. Two curves show lower incidence for Atorvastatin than placebo, with hazard ratio (HR) and p-value displayed, indicating statistical analysis of treatment effect.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 2)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint across four years, and the y-axis indicates cumulative hazard percentage. The graph includes hazard ratio data (HR 0.63) with confidence intervals and p-value, illustrating outcome differences during the study period.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 3)

A line graph comparing the proportion of subjects experiencing a major cardiovascular event over time between two atorvastatin dosage groups: 10 mg (dotted line) and 80 mg (solid line). The x-axis shows time in years to the first major cardiovascular endpoint up to 5 years, and the y-axis indicates the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78, 95% CI 0.69-0.89) with a p-value of 0.0002, reflecting statistical comparison between groups.*

FDA Label Image

Image Description (Atorvastat Cal Usp Structure)

Chemical structure of atorvastatin calcium showing its molecular arrangement including aromatic rings, fluorine substituent, and calcium ions complexed with three water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.